Remission InductionVincristineInduction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsCytarabineDaunorubicinCombined Modality TherapyAsparaginaseCyclophosphamideDoxorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteTreatment OutcomeCisplatinRemission, SpontaneousDisease-Free SurvivalEtoposideMethotrexateChemotherapy, AdjuvantAntineoplastic AgentsSurvival AnalysisIdarubicinPrognosisLeukemia, MyeloidDrug Administration Schedule6-MercaptopurineSurvival RateThioguanineRecurrenceNeoplasm StagingPrednisoneAcute DiseaseNeoadjuvant TherapyLeukemia, LymphoidNeoplasm, ResidualBone MarrowVinblastineBleomycinHead and Neck NeoplasmsIfosfamideLung NeoplasmsTime FactorsCarboplatinPaclitaxelFollow-Up StudiesLeukemiaTaxoidsCarcinoma, Squamous CellFluorouracilLeukemia, Promyelocytic, AcutePrednisoloneBone Marrow TransplantationTransplantation, AutologousRadiotherapy, AdjuvantHematopoietic Stem Cell TransplantationClinical Trials as TopicDexamethasoneProspective StudiesAntineoplastic Agents, PhytogenicMelphalanBlast CrisisNeoplasm Recurrence, LocalEnzyme InductionLymphoma, Non-HodgkinSalvage TherapyChemoradiotherapyRadiotherapyCarcinoma, Non-Small-Cell LungRadiotherapy DosageLomustineLaryngectomyAntibodies, MonoclonalNeutropeniaLeukocyte CountBreast NeoplasmsVindesineHypopharyngeal NeoplasmsDrug Resistance, NeoplasmKaplan-Meier EstimateGranulocyte Colony-Stimulating FactorRetrospective StudiesDose-Response Relationship, DrugDeoxycytidineMitoxantroneP-GlycoproteinAntimetabolites, AntineoplasticTesticular NeoplasmsNasopharyngeal NeoplasmsCranial IrradiationAntibodies, Monoclonal, Murine-DerivedPlatelet CountMesnaHodgkin DiseaseAntibiotics, AntineoplasticRadiotherapy, High-EnergyLeukopeniaTransplantation, HomologousDrug Therapy, CombinationInjections, SpinalMultiple Myeloma